Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences


Posted on: 07 Feb 18

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will report its fourth quarter and full year 2017 financial results prior to the NASDAQ market open on Wednesday, February 14, 2018. Intercept management will conduct a conference call and audio webcast on Wednesday, February 14, 2018 at 8:30 a.m. Eastern Time to discuss these results.

Intercept management will also be presenting at the following investor conferences:

  • LEERINK Partners 7th Annual Global Healthcare Conference on February 15, 2018 at 2:00 p.m. Eastern Time
  • 2018 RBC Capital Markets Global Healthcare Conference on February 21, 2018 at 10:00 a.m. Eastern Time
  • 38th Annual Cowen Health Care Conference on March 12, 2018 at 2:10 p.m. Eastern Time

Webcast information for these events will be available on the Investors page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.

CONTACT: For more information about

         Intercept Pharmaceuticals, please contact:
       

         Intercept Pharmaceuticals:

         Mark Vignola

         +1-646-747-1000

         investors@interceptpharma.com

     

         Media inquiries: media@interceptpharma.com

        

         Investor inquiries: investors@interceptpharma.com

GlobeNewswire
globenewswire.com

Last updated on: 08/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.